Ostentus Therapeutics develops plant-derived treatments that utilize a proprietary extraction process to isolate active compounds targeting intracellular pathways in cancer cells, leading to inhibited growth and induced apoptosis. This approach provides patients with effective cancer therapies that have high efficacy and reduced side effects compared to traditional treatments.
Funding
Funding not disclosed
Founders
Product
Problem
Current cancer treatments often have significant side effects and limited efficacy due to their impact on both cancerous and healthy cells. There is a need for more targeted therapies that can selectively inhibit cancer cell growth and induce apoptosis while minimizing harm to normal tissues.
Solution
Ostentus Therapeutics is developing a novel class of plant-derived anti-cancer drugs that target intracellular pathways specific to cancer cells. Their proprietary extraction process isolates active compounds that selectively inhibit the growth of cancer cells and induce programmed cell death (apoptosis). This targeted approach aims to provide cancer patients with therapies that exhibit high efficacy and reduced side effects compared to traditional chemotherapy and radiation treatments. By focusing on intracellular mechanisms, Ostentus Therapeutics seeks to disrupt cancer progression at its core, offering a more effective and safer treatment option. The company's lead compound, OST-01, is currently under research and development.
Target Audience
The primary target audience includes cancer patients seeking more effective and safer treatment options, as well as oncologists and medical professionals looking for innovative therapies with reduced side effects.
Features
- Proprietary extraction process for isolating active anti-cancer compounds from plants
- Targeted approach to inhibit intracellular pathways specific to cancer cells
- Induction of apoptosis (programmed cell death) in cancer cells
- Reduced side effects compared to traditional cancer treatments
- Lead compound OST-01 under development